Alanosine in Treating Patients With Cancer

Clinical trial NCT00062283 · COMPLETED

Trial details

NCT number: NCT00062283
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Malignant Mesothelioma Pancreatic Cancer Sarcoma

Start date: 2003-03-01
Primary completion: 2005-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.